Abstract TMP17: Revacept, an Inhibitor of Platelet Adhesion in Patients With Symptomatic Carotid Artery Stenosis. Safety Data From the International Randomized Multicenter Revacept CS02 Phase 2 Study

Timo Uphaus,Toby Richards,Christian Weimar,Hermann Neugebauer,Sven Poli,Karin Weissenborn,Christopher H.E. Imray,Dominik Michalski,Hisham Rashid,Ian M. Loftus,Martin A Ritter,Till Karsten Hauser,Götz Münch,Holger Poppert,Klaus Gröschel

Abstract TMP17: Revacept, an Inhibitor of Platelet Adhesion in Patients With Symptomatic Carotid Artery Stenosis. Safety Data From the International Randomized Multicenter Revacept CS02 Phase 2 Study

2020

Timo Uphaus
Toby Richards
Christian Weimar
Hermann Neugebauer
Sven Poli
Karin Weissenborn
Christopher H.E. Imray
Dominik Michalski
Hisham Rashid
Ian M. Loftus
Martin A Ritter
Till Karsten Hauser
Götz Münch
Holger Poppert
Klaus Gröschel

Introduction: Revacept is a novel vascular lesion-directed inhibitor of platelet adhesion and thrombus formation, exhibiting no effects on the homeostatic functions of circulating platelets. Object...

Keywords:

Carotid endarterectomy
in patient
Stent
Medicine
Cardiology
Phases of clinical research
Platelet
Thrombus
platelet adhesion
Internal medicine
Homeostasis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations